Re: Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study
(Source: BMJ Comments)
Source: BMJ Comments - September 17, 2018 Category: General Medicine Source Type: forums
Re: Sulfonylureas as second line treatment for type 2 diabetes: different approaches used for mortality analysis in observation studies of T2D patients can present discrepant results.
(Source: BMJ Comments)
Source: BMJ Comments - August 29, 2018 Category: General Medicine Source Type: forums
Re: Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study
(Source: BMJ Comments)
Source: BMJ Comments - July 25, 2018 Category: General Medicine Source Type: forums
Re: Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study - Lesson learned is using the two-edged sword judiciously
(Source: BMJ Comments)
Source: BMJ Comments - July 22, 2018 Category: General Medicine Source Type: forums
Re: Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study
(Source: BMJ Comments)
Source: BMJ Comments - July 22, 2018 Category: General Medicine Source Type: forums
Re: Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study - Lesson learned is using the two-edged sword judiciously
(Source: BMJ Comments)
Source: BMJ Comments - July 22, 2018 Category: General Medicine Source Type: forums
Re: Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study
(Source: BMJ Comments)
Source: BMJ Comments - July 20, 2018 Category: General Medicine Source Type: forums
Re: Dietary and nutritional approaches for prevention and management of type 2 diabetes
(Source: BMJ Comments)
Source: BMJ Comments - July 15, 2018 Category: General Medicine Source Type: forums
Re: Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study
(Source: BMJ Comments)
Source: BMJ Comments - March 30, 2018 Category: General Medicine Source Type: forums
Wamc 3.74, 514 (125 cars) ca
Year in school: 4th year, will be in gap year during 2018-2019 application cycle
Country/state of residence: CA (PR), but I live in Canada.
Cumulative GPA: 3.74 Science GPA: 3.66
MCAT Scores: 514 (130/125/129/130)
Research – include any abstracts/posters/publications and how you were credited (eg. First author, senior author, etc): 100 hours in bioinformatics, 300 hours in clinical research for type 2 diabetes. Did 1 poster presentation at university conference. Maybe one publication this...
WAMC 3.74, 514 (125 CARS) CA (Source: Student Doctor Network)
Source: Student Doctor Network - December 28, 2017 Category: Universities & Medical Training Authors: TheGreatAli Source Type: forums
Re: Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study
(Source: BMJ Comments)
Source: BMJ Comments - November 24, 2017 Category: General Medicine Source Type: forums
Re: Beating type 2 diabetes into remission
(Source: BMJ Comments)
Source: BMJ Comments - October 5, 2017 Category: General Medicine Source Type: forums
